Astellas Pharma Inc. 2024 Q3 – Results – Earnings Call Presentation
This article was written byFollowSeeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects. We ...
This article was written byFollowSeeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects. We ...
An Astellas Pharma drug designed to address a novel target has landed a highly anticipated FDA approval for a rare ...
Here’s part 2 of MedCity News’ Q&A with Astellas Pharma CEO Naoki Okamura, who was in South San Francisco last ...
Astellas Pharma’s path to winning the first drug approval for a particular promising gastrointestinal cancer target has hit a detour. ...
Copyright © 2024 EuroAsia24 News.
EuroAsia24 News is not responsible for the content of external sites.